I+D y actividades científico-profesionales, bases de las relaciones entre industria farmacéutica y organizaciones y profesionales sanitarios

by Farmaindustria

En 2015, la industria farmacéutica asentada en España invirtió, aproximadamente, 190 millones de euros en contratos con organizaciones y profesionales sanitarios para proyectos de I+D y contribuyó...

Read more

Avizorex Pharma submits clinical trial application for its lead compound AVX-012 for dry eye syndrome

by Inveready

AVX-012, a Small Molecule with a novel mechanism of action, to be investigated as a potential new treatment for mild to moderate Dry Eye Syndrome.

Read more

Casi un centenar de centros sanitarios andaluces colaboran con la industria farmacéutica en ensayos clínicos

by Farmaindustria

​En la última década, 92 centros sanitarios andaluces, tanto públicos como privados, han colaborado con la industria farmacéutica innovadora en el desarrollo de 2.413 ensayos clínicos, en los q...

Read more

Oryzon nominates ORY-3001, a specific LSD1 inhibitor, next drug candidate to enter preclinical development in non-oncological indications

by Oryzon Genomics

Oryzon Genomics (ISIN Code: ES0167733015 , ORY ), a public clinical - stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced ...

Read more

From the Antarctic Sea to the SaaS platform

by Mind the Byte

So far, this group of experts from the UB and IRBio have discovered bioactive molecules like hodgsonal, terpenoid acylglycerols, glassponsine, granuloside, illudalanes, triterpene glycosides, and some...

Read more

Maps show how drugs reverse alterations in hepatitis C-infected cells

by Centro Nacional de Biotecnología (CNB)

Researchers at the Centro Nacional de Biotecnología of the CSIC (CNB-CSIC) and the ALBA Synchrotron have now looked inside an infected cell in three dimensions and seen how the virus greatly distorts...

Read more

Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102

by Ysios Capital

MIN-102 is a differentiated PPAR gamma agonist with a superior profile for central nervous system related diseases. It has shown robust preclinical proof of concept. The aim of the Phase 1 study is to...

Read more

El programa Horizon 2020 respalda la nanomedicina para potenciar la terapia contra el cáncer de páncreas

by Vall d’Hebron

​En los últimos años, la administración de fármacos derivados de la investigación “nano” ha demostrado tener un gran potencial como terapia contra el cáncer. La nanoterapia implica la util...

Read more

Various miRNAs predict the effect of anti-angiogenic agents on kidney cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

To date there are no predictive biomarkers for metastatic renal cancer. Identifying these molecules could improve patient management. The authors of this study propose a model predictive of TKI respon...

Read more

A ‘Big Data’ approach to developing cancer drugs

by IBEC - Institut de Bioenginyeria de Catalunya

The researchers started from 1,000 cancer cell lines derived from 29 different cell types and different organs to simultaneously obtain their genetic alterations (mutations and copy number of genes), ...

Read more

New multicomponent reactions to design active compounds against trypanosomiasis

by Universitat de Barcelona

The high-impact chemical journal Angewandte Chemie International Edition presents a scientific work on multicomponent reactions of great interest to obtain new active compounds against parasites causi...

Read more

Las líneas celulares de cáncer ayudan a predecir el efecto de los fármacos en el tratamiento de tumores

by UPF - Universitat Pompeu Fabra

​Un estudio publicado en la revista científica Cell demuestra que las líneas celulares de cáncer derivadas de pacientes albergan muchos de los cambios genéticos que se encuentran en los tumores ...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream